Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Affymetrix Inc.

Mar 2007
Affymetrix Inc. of Santa Clara, Calif., has granted Tessarae Inc. of McLean, Va., nonexclusive access to its microarray technology. The TessArray kits incorporate Affymetrix CustomSeq resequencing arrays and can detect and identify strains of viral and bacterial pathogens associated with upper respiratory diseases on the basis of target genome sequences. The epidemiological tests are intended primarily for public health and bioterrorism surveillance applications.

Affymetrix Inc.Biophotonicsbioterrorism surveillance applicationsmicroarray technologyNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!